
    
      1. CD11b expression level is a prognostic biomarker for AML patient. CD11b positivity could
           predict a poor prognosis for AML patients.

        2. CD56 antigen expression, an inexpensive, easy to detect and reproduce index, is closely
           related to the prognosis of AML patients
    
  